Alert
Please keep in mind that merely contacting Nelson Mullins Riley & Scarborough LLP will not establish an attorney-client relationship. Nelson Mullins cannot represent you until the firm knows there would not be a conflict of interest, and the firm determines that it is otherwise able to accept the engagement. Accordingly, please do not send Nelson Mullins any information or documents until a formal attorney-client relationship has been established through an interview with an attorney and authorized in the form of an engagement letter from Nelson Mullins. Any information or documents sent prior to your receipt of an engagement letter cannot be treated as confidences, secrets or protected information of any nature. Clicking "Submit" acknowledges that you understand and agree with this notice.
The LatestView All
January 22, 2024
Nashville partner Bob Wade will participate in the Health Care Compliance Association (HCCA) Anchorage Regional Compliance & Ethics Conference in Feb. 22-23. The conference will include topics on regulatory requirements, compliance enforcement, risk management, and maintaining an effective compliance program. Attendees will have the opportunity to earn live Compliance Certification Board (CCB) continuing education units (CEUs) and network with other professionals.
Anchorage Regional Compliance & Ethics Conference
Idea Exchange
Jane E. Remillard
Partner
One Financial Center
Suite 3500
Boston, MA 02111
Suite 3500
Boston, MA 02111
jane.remillard@nelsonmullins.com
Jane leads the Life Sciences Intellectual Property Team and has over 30 years of experience providing worldwide patent counseling in the fields of biotechnology and pharmaceuticals. Jane’s practice focuses on developing and implementing effective IP strategies, building strong patent portfolios, and facilitating commercialization of products, particularly antibody-based therapeutics, through all phases of development.
Jane leads the Life Sciences Intellectual Property Team and has over 30 years of experience providing worldwide patent counseling in the fields of biotechnology and pharmaceuticals. Jane’s practice focuses on developing and implementing effective IP strategies, building strong patent portfolios, and facilitating commercialization of products, particularly antibody-based therapeutics, through all phases of development.
Experience
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
Jane's experience includes:
- Providing strategic patent counseling including patent preparation, prosecution, freedom to operate evaluations, re-examinations, re-issues, inter partes reviews, and oppositions in a broad variety of technologies and discovery platforms, including immunotherapeutics, recombinant proteins, peptides, biomarkers, diagnostics, vaccines, stem cells, gene therapy and cell based assays.
- Developing and implementing effective IP strategies, including building strong patent portfolios to protect products from discovery through next generation.
- Conducting due diligence evaluations for collaborations, acquisitions, licensing, and financing transactions.
- Representing clients in private and public offerings, both in the United States and abroad.
- Advising clients in assessing the strength of intellectual property assets held by prospective candidates for investment.
- Preparing, prosecuting, and opining on patents in the fields of immunology, oncology, virology, neurology, and cell biology for clients ranging from start-up biotechnology companies to established pharmaceutical corporations.
Education
- Boston University School of Law, JD (1993)
- Princeton University, BA, Molecular Biology (1989)
Admissions
- Massachusetts
- U.S. Patent & Trademark Office
Practice Areas
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.
Jane's experience includes:
- Providing strategic patent counseling including patent preparation, prosecution, freedom to operate evaluations, re-examinations, re-issues, inter partes reviews, and oppositions in a broad variety of technologies and discovery platforms, including immunotherapeutics, recombinant proteins, peptides, biomarkers, diagnostics, vaccines, stem cells, gene therapy and cell based assays.
- Developing and implementing effective IP strategies, including building strong patent portfolios to protect products from discovery through next generation.
- Conducting due diligence evaluations for collaborations, acquisitions, licensing, and financing transactions.
- Representing clients in private and public offerings, both in the United States and abroad.
- Advising clients in assessing the strength of intellectual property assets held by prospective candidates for investment.
- Preparing, prosecuting, and opining on patents in the fields of immunology, oncology, virology, neurology, and cell biology for clients ranging from start-up biotechnology companies to established pharmaceutical corporations.
Media
Recognitions
The bar rules of some states require that the standards for an attorney's inclusion in certain public accolades or recognitions be provided. When such accolades or recognitions are listed, a hyperlink is provided that leads to a description of the respective selection methodology.
- Massachusetts Go To Intellectual Property Attorneys, Massachusetts Lawyers Weekly (2021)
- Patent Strategy Attorney of the Year, LMG Life Sciences (2021)
- Managing Intellectual Property magazine, Patent Star (2020–2023), Top 250 Women in IP (2022–2023)
- Profiles in Diversity Journal, Women Worth Watching in STEM® (2020)
- LMG Life Sciences, Star in Intellectual Property for Patent Strategy & Management (2019–2023); shortlisted for Patent Strategy Attorney of the Year Award (2021 and 2022); Winner of Patent Strategy Attorney of the Year Award (2021)
- The Best Lawyers in America®, Patent Law (2015–2024)
- Lawyer of the Year in Boston for Patent Law (2022)
- Chambers USA: America's Leading Lawyers for Business, Intellectual Property – Massachusetts (2014–2023)
- New England Super Lawyers, Intellectual Property (2006–2007, 2009–2023)
- Top Women Attorneys in Massachusetts (2014)
- Top 50 Women Massachusetts (2011–2013)
- Top 100 Massachusetts (2011)
- Honoree of the Annual Boston University Law Women in Law Conference (2009)
Professional Activities
- Intellectual Property Owners Association
- Pharmaceutical & Biotechnology Issues Committee
- Massachusetts Bar
- American Intellectual Property Law Association
- Boston Patent Law Association
- Women’s Bar Association
Jane leads the Life Sciences Intellectual Property Team and has over 30 years of experience providing worldwide patent counseling in the fields of biotechnology and pharmaceuticals. Jane’s practice focuses on developing and implementing effective IP strategies, building strong patent portfolios, and facilitating commercialization of products, particularly antibody-based therapeutics, through all phases of development.
Experience
Following is a selected sampling of matters and is provided for informational purposes only. Past success does not indicate the likelihood of success in any future matter.Jane's experience includes:
- Providing strategic patent counseling including patent preparation, prosecution, freedom to operate evaluations, re-examinations, re-issues, inter partes reviews, and oppositions in a broad variety of technologies and discovery platforms, including immunotherapeutics, recombinant proteins, peptides, biomarkers, diagnostics, vaccines, stem cells, gene therapy and cell based assays.
- Developing and implementing effective IP strategies, including building strong patent portfolios to protect products from discovery through next generation.
- Conducting due diligence evaluations for collaborations, acquisitions, licensing, and financing transactions.
- Representing clients in private and public offerings, both in the United States and abroad.
- Advising clients in assessing the strength of intellectual property assets held by prospective candidates for investment.
- Preparing, prosecuting, and opining on patents in the fields of immunology, oncology, virology, neurology, and cell biology for clients ranging from start-up biotechnology companies to established pharmaceutical corporations.
Education
- Boston University School of Law, JD (1993)
- Princeton University, BA, Molecular Biology (1989)
Admissions
- Massachusetts
- U.S. Patent & Trademark Office
Practice Areas
The bar rules of some states require that the standards for an attorney's inclusion in certain public accolades or recognitions be provided. When such accolades or recognitions are listed, a hyperlink is provided that leads to a description of the respective selection methodology.
- Massachusetts Go To Intellectual Property Attorneys, Massachusetts Lawyers Weekly (2021)
- Patent Strategy Attorney of the Year, LMG Life Sciences (2021)
- Managing Intellectual Property magazine, Patent Star (2020–2023), Top 250 Women in IP (2022–2023)
- Profiles in Diversity Journal, Women Worth Watching in STEM® (2020)
- LMG Life Sciences, Star in Intellectual Property for Patent Strategy & Management (2019–2023); shortlisted for Patent Strategy Attorney of the Year Award (2021 and 2022); Winner of Patent Strategy Attorney of the Year Award (2021)
- The Best Lawyers in America®, Patent Law (2015–2024)
- Lawyer of the Year in Boston for Patent Law (2022)
- Chambers USA: America's Leading Lawyers for Business, Intellectual Property – Massachusetts (2014–2023)
- New England Super Lawyers, Intellectual Property (2006–2007, 2009–2023)
- Top Women Attorneys in Massachusetts (2014)
- Top 50 Women Massachusetts (2011–2013)
- Top 100 Massachusetts (2011)
- Honoree of the Annual Boston University Law Women in Law Conference (2009)
- Intellectual Property Owners Association
- Pharmaceutical & Biotechnology Issues Committee
- Massachusetts Bar
- American Intellectual Property Law Association
- Boston Patent Law Association
- Women’s Bar Association
Highlights from the Firm’s Insights
Apologizing Still Works, But Ensure It Is Done Correctly
February 22, 2024
Protecting Your Brand: Steps Every Brand Owner Should Know
February 20, 2024
To Appeal or Not to Appeal? Ten Considerations Guiding Whether...
February 19, 2024
Gold Dome Report - Legislative Day 25
February 22, 2024
FCC CPNI Certification and Privacy Rules Update
February 21, 2024
Gold Dome Report – Legislative Day 24
February 21, 2024